Kenya National AIDS & STI Control Programme
13
1
1
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
46%
6 trials in Phase 3/4
8%
1 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
PrEP My Way: A Hybrid Type 1 Clinical Effectiveness-implementation Trial to Promote PrEP Persistence Among Young Kenyan Women
Role: collaborator
PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in Kenya
Role: collaborator
Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP
Role: collaborator
Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)
Role: collaborator
The Partners Scale-Up Project
Role: collaborator
Testing and Linkage to Care for Injecting Drug Users in Kenya
Role: collaborator
Simplifying the Shang Ring Technique for Circumcision of Men and Boys
Role: collaborator
Evaluation of Healing at Three Time Intervals and Potential for Spontaneous Detachment
Role: collaborator
Use of the Shang Ring Circumcision Device in Boys Below 18 Years Old in Kenya
Role: collaborator
Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost
Role: collaborator
Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in Kenya
Role: collaborator
A Prospective Field Study: Introducing the Shang Ring in Routine Clinical Settings
Role: collaborator
Comparison of the Shang Ring With Conventional Surgical Methods
Role: collaborator
All 13 trials loaded